198 related articles for article (PubMed ID: 37909445)
1. [Psychedelics and treatment of mental disorders: A survey of attitudes and knowledge among psychiatrists, general practitioners and psychologists in Iceland].
Olafsson RP; Kvaran K; Ketilsdottir K; Hallgrimsdottir K; Sigurdsson EL; Sigurdsson E
Laeknabladid; 2023 Nov; 109(11):495-503. PubMed ID: 37909445
[TBL] [Abstract][Full Text] [Related]
2. A survey of Australian psychiatrists' and psychiatry trainees' knowledge of and attitudes towards psychedelics in the treatment of psychiatric disorders.
Grover C; Monds L; Montebello M
Australas Psychiatry; 2023 Jun; 31(3):329-335. PubMed ID: 36753675
[TBL] [Abstract][Full Text] [Related]
3. Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States.
Davis AK; Agin-Liebes G; España M; Pilecki B; Luoma J
J Psychoactive Drugs; 2022; 54(4):309-318. PubMed ID: 34468293
[TBL] [Abstract][Full Text] [Related]
4. Psychedelic perceptions: mental health service user attitudes to psilocybin therapy.
Corrigan K; Haran M; McCandliss C; McManus R; Cleary S; Trant R; Kelly Y; Ledden K; Rush G; O'Keane V; Kelly JR
Ir J Med Sci; 2022 Jun; 191(3):1385-1397. PubMed ID: 34131812
[TBL] [Abstract][Full Text] [Related]
5. Attitudes of European psychiatrists on psychedelics: a qualitative study.
Žuljević MF; Breški N; Kaliterna M; Hren D
Front Psychiatry; 2024; 15():1411234. PubMed ID: 38855648
[TBL] [Abstract][Full Text] [Related]
6. Psychologists' and psychotherapists' knowledge, attitudes, and clinical practices regarding the therapeutic use of psychedelics.
Kucsera A; Suppes T; Haug NA
Clin Psychol Psychother; 2023; 30(6):1369-1379. PubMed ID: 37394242
[TBL] [Abstract][Full Text] [Related]
7. Attitudes on Psychedelics in a Sample of Croatian Mental Health Professionals: A Cross-Sectional National Survey Study.
Mastelić T; Borovina Marasović T; Žuljević MF; Sučević Ercegovac M; Kaliterna M; Pleić N; Vukorepa D; Topić J; Žuljan Cvitanović M; Lasić D; Uglešić B; Kozina S; Glavina T
J Psychoactive Drugs; 2024 Jun; ():1-10. PubMed ID: 38934459
[TBL] [Abstract][Full Text] [Related]
8. The prescription of psychedelic therapies in Australia and New Zealand: A brief survey of psychiatrists.
Berger JJ; Fitzgerald PB
Australas Psychiatry; 2023 Apr; 31(2):190-194. PubMed ID: 36779819
[TBL] [Abstract][Full Text] [Related]
9. UK medical students' self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study.
Song-Smith C; Jacobs E; Rucker J; Saint M; Cooke J; Schlosser M
BMJ Open; 2024 Mar; 14(3):e083595. PubMed ID: 38485474
[TBL] [Abstract][Full Text] [Related]
10. [Attitudes of Mental Health Experts Towards Psilocybin].
Schmidt C; Wolff M; Gründer G; Jungaberle H
Fortschr Neurol Psychiatr; 2023 Mar; 91(3):80-87. PubMed ID: 35724682
[TBL] [Abstract][Full Text] [Related]
11. Beliefs about the helpfulness of interventions for mental disorders: a comparison of general practitioners, psychiatrists and clinical psychologists.
Jorm AF; Korten AE; Jacomb PA; Rodgers B; Pollitt P
Aust N Z J Psychiatry; 1997 Dec; 31(6):844-51. PubMed ID: 9483257
[TBL] [Abstract][Full Text] [Related]
12. Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.
Barnett BS; Greer GR
J Acad Consult Liaison Psychiatry; 2021; 62(4):460-471. PubMed ID: 34210406
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of psychedelics in psychiatry, a systematic review of the literature].
Berkovitch L; Roméo B; Karila L; Gaillard R; Benyamina A
Encephale; 2021 Aug; 47(4):376-387. PubMed ID: 33888297
[TBL] [Abstract][Full Text] [Related]
14. Addiction specialists' attitudes toward psychedelics: A National Survey.
Kim A; Suzuki J
Am J Addict; 2023 Nov; 32(6):606-609. PubMed ID: 37550848
[TBL] [Abstract][Full Text] [Related]
15. Psychedelic Knowledge and Opinions in Psychiatrists at Two Professional Conferences: An Exploratory Survey.
Barnett BS; Beaussant Y; King F; Doblin R
J Psychoactive Drugs; 2022; 54(3):269-277. PubMed ID: 34409921
[TBL] [Abstract][Full Text] [Related]
16. Psychedelics and mental health: a population study.
Krebs TS; Johansen PØ
PLoS One; 2013; 8(8):e63972. PubMed ID: 23976938
[TBL] [Abstract][Full Text] [Related]
17. Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia.
Nadeem Z; Parker S; McGovern H; Oestreich LK
Aust N Z J Psychiatry; 2024 Jun; ():48674241261779. PubMed ID: 38907608
[TBL] [Abstract][Full Text] [Related]
18. Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities.
Rosenbaum D; Weissman C; Anderson T; Petranker R; Dinh-Williams LA; Hui K; Hapke E
J Psychopharmacol; 2020 Jun; 34(6):612-622. PubMed ID: 32108529
[TBL] [Abstract][Full Text] [Related]
19. Classical psychedelics in psychiatry - renaissance of interest and therapeutic perspectives.
Jachimowski A; Kucia K
Psychiatr Pol; 2023 Jun; 57(3):657-670. PubMed ID: 38043078
[TBL] [Abstract][Full Text] [Related]
20. The Therapeutic Potential of Psilocybin.
Lowe H; Toyang N; Steele B; Valentine H; Grant J; Ali A; Ngwa W; Gordon L
Molecules; 2021 May; 26(10):. PubMed ID: 34063505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
